SCHEMBL1961140

SCHEMBL1961140

CC1(C)OB(c2ccc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc2)OC1(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 13/20 0.61
LPL P06858 12/20 0.61
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
HDAC4 P56524 1/20 0.38
P4HB P07237 1/20 0.37
KEAP1 Q14145 1/20 0.37
NFE2L2 Q16236 1/20 0.37
CA12 O43570 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29492600 0.95 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL29662424 0.95 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL792421 0.95 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL25470674 0.92 LIPG (0.51) LIPGLPLKDM4EATML3MBTL1
SCHEMBL21416066 0.92 LIPG (0.51) LIPGLPLKDM4EATML3MBTL1
SCHEMBL11987879 0.92 LIPG (0.58) LIPGLPLKDM4EATML3MBTL1
SCHEMBL21157799 0.91 LIPG (0.58) LIPGLPLKDM4EATML3MBTL1
SCHEMBL21974388 0.91 LIPG (0.58) LIPGLPLKDM4EATML3MBTL1
SCHEMBL23232682 0.90 LIPG (0.57) LIPGLPLKDM4EATML3MBTL1
SCHEMBL26416412 0.90 LIPG (0.56) LIPGLPLKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10978647-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-04-13 US disclosed
US-10978647-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2021-04-13 US disclosed
US-10435390-B2 Heterocyclic compound and organic light emitting device including same LG CHEM, LTD. (KR) 2019-10-08 US disclosed
US-20180051007-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME LG CHEM, LTD. (KR) 2018-02-22 US disclosed
US-20180051007-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME LG CHEM, LTD. (KR) 2018-02-22 US disclosed
US-20170244049-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-08-24 US disclosed
EP-2668247-B1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING OPTIONALLY SUBSTITUTED TERPHENYL AND QUATERPHENYL COMPOUNDS NITTO DENKO CORP (JP) 2016-12-28 EP disclosed
US-9425408-B2 Organic light emitting host materials NITTO DENKO CORPORATION (JP) 2016-08-23 US disclosed
US-9425408-B2 Organic light emitting host materials NITTO DENKO CORPORATION (JP) 2016-08-23 US disclosed
US-9425408-B2 Organic light emitting host materials NITTO DENKO CORPORATION (JP) 2016-08-23 US disclosed
US-8426040-B2 Compounds for use in light-emitting devices NITTO DENKO CORPORATION (JP) 2013-04-23 US disclosed
US-8426040-B2 Compounds for use in light-emitting devices NITTO DENKO CORPORATION (JP) 2013-04-23 US disclosed
US-20120197179-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING OPTIONALLY SUBSTITUTED TERPHENYL AND QUATERPHENYL COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-08-02 US disclosed
US-20120197179-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING OPTIONALLY SUBSTITUTED TERPHENYL AND QUATERPHENYL COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-08-02 US disclosed
US-20120197179-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING OPTIONALLY SUBSTITUTED TERPHENYL AND QUATERPHENYL COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-08-02 US disclosed
WO-2012103380-A1 PHOTOTHERAPY DEVICES AND METHODS COMPRISING OPTIONALLY SUBSTITUTED TERPHENYL AND QUATERPHENYL COMPOUNDS NITTO DENKO CORPORATION (JP) 2012-08-02 WO disclosed
WO-2012088294-A1 BENZOIMIDAZOLE DERIVATIVES FOR USE IN LIGHT - EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2012-06-28 WO disclosed
US-20110140093-A1 COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2011-06-16 US disclosed
US-20110140093-A1 COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2011-06-16 US disclosed
US-20110140093-A1 COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES NITTO DENKO CORPORATION (JP) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10435390-B2 Heterocyclic compound and organic light emitting device including same CRY1, CRY2, PER2 LIPG 2564/4885LPL 2423/4885KDM4E 2380/4885
US-20170244049-A1 ORGANIC LIGHT-EMITTING DIODE MATERIALS CYBA, DDT, DRD1 LIPG 1334/4885LPL 575/4885KDM4E 2858/4885
US-20180051007-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING SAME CRY1, CRY2, PER2 LIPG 2564/4885LPL 2423/4885KDM4E 2380/4885
US-10978647-B2 Organic electroluminescent materials and devices SLCO4C1, SLCO2A1, SLC25A21 LIPG 903/4885LPL 1179/4885KDM4E 3786/4885
US-20110140093-A1 COMPOUNDS FOR USE IN LIGHT-EMITTING DEVICES NR2E3, CYP3A4, UGT1A4 LIPG 446/4885LPL 1115/4885KDM4E 3169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.